Abstract
The emergence of carbapenem-resistant Pseudomonas aeruginosa in the lung of a patient with cystic fibrosis was evaluated. A single strain of P. aeruginosa persisted during a 3-year study despite antipseudomonal treatment. A stepwise decrease in carbapenem susceptibility leading to resistance was observed in the absence of carbapenem treatment. These data suggest that chronic exposure to unrelated drug classes may be an important determinant for the emergence of carbapenem resistance in P. aeruginosa.
| Original language | English (US) |
|---|---|
| Pages (from-to) | e137-e141 |
| Journal | Clinical Infectious Diseases |
| Volume | 46 |
| Issue number | 12 |
| DOIs | |
| State | Published - Jun 15 2008 |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases
Fingerprint Dive into the research topics of 'Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy'. Together they form a unique fingerprint.
Cite this
Wolter, D. J., Acquazzino, D., Goering, R. V., Sammut, P., Khalaf, N., & Hanson, N. D. (2008). Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy. Clinical Infectious Diseases, 46(12), e137-e141. https://doi.org/10.1086/588484